Mauritz, Matthias http://orcid.org/0000-0002-5204-393X
Poppert, Kai-Nicolas
Trinka, Eugen
Mutzenbach, Sebastian
Funding for this research was provided by:
Paracelsus Medical University
Article History
Accepted: 28 October 2022
First Online: 1 December 2022
Compliance with Ethical Standards
:
: Matthias Mauritz, Kai-Nicolas Poppert and Sebastian Mutzenbach report no conflicts of interest. Eugen Trinka reports personal fees from EVER Pharma, Marinus, Arvelle, Angelini, Argenx, Medtronic, Bial-Portela & Cª, NewBridge, GL Pharma, GlaxoSmithKline, Boehringer Ingelheim, LivaNova, Eisai, UCB, Biogen, Sanofi, Jazz Pharmaceuticals, and Actavis. His institution received grants from Biogen, UCB Pharma, Eisai, Red Bull, Merck, Bayer, the European Union, FWF Österreichischer Fond zur Wissenschaftsforderung, Bundesministerium für Wissenschaft und Forschung, and Jubiläumsfond der Österreichischen Nationalbank.